(19)
(11) EP 1 015 036 A1

(12)

(43) Date of publication:
05.07.2000 Bulletin 2000/27

(21) Application number: 98941611.0

(22) Date of filing: 07.09.1998
(51) International Patent Classification (IPC)7A61K 48/00, C12N 5/10
(86) International application number:
PCT/GB9802/693
(87) International publication number:
WO 9912/574 (18.03.1999 Gazette 1999/11)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.09.1997 GB 9718872
07.11.1997 GB 9723448
02.03.1998 US 76448 P

(71) Applicant: MEDICAL RESEARCH COUNCIL
London W1N 4AL (GB)

(72) Inventors:
  • ALVAREZ-VALLINA, Luis,Hosp.Univ. Puerta de Hierro
    E-28025 Madrid (ES)
  • AGHA-MOHAMMADI, Siamak
    Pittsburgh, PA 15213 (US)
  • RUSSELL, Stephen, James
    Rochester, MN 55902 (US)
  • HAWKINS, Robert
    PrestburyCheshire SK10 4YG (GB)

(74) Representative: Lipscombe, Martin John 
Keith W Nash & Co,Pearl Assurance House,90-92 Regent Street
Cambridge CB2 1DP
Cambridge CB2 1DP (GB)

   


(54) IMPROVEMENTS IN OR RELATING TO EXPRESSION OF IMMUNOGENIC SUBSTANCES